Position estimating in peer-to-peer networks

We present two algorithms for indoor positioning estimation in peer-to-peer networks. The setup is a network of two types of devices: reference devices with a known location and blindfolded devices that can determine distances to reference devices and each other. From this information the blindfolded devices try to estimate their positions. A typical scenario is navigation inside a shopping mall where devices in the parking lot can make contact with GPS satellites, whereas devices inside the building make contact with each other, devices on the parking lot, and devices fixed to the building. The devices can measure their in-between distances, with some measurement error, and exchange positioning information. However, other devices might only know their position with some error. We present two algorithms for positioning estimation in such a peer-to-peer network. The first one is purely geometric and is based on Euclidean geometry and intersecting spheres. We rewrite the information to a linear system, which is typically overdetermined. We use least squares to ??nd the best estimate for a device its position. The second approach can be considered as a probabilistic version of the geometric approach. We estimate the probability density function that a device is located at a position given a probability density function for the positions of the other devices in the network, and a probability density function of the measured distances. First we study the case with a distance measurement to a single other user, then we focus on multiple other users. We give an approximation algorithm that is the probabilistic analogue of the intersecting spheres method. We show some simulated results where ambiguous data lead to well defined probability distributions for the position of a device. We conclude with some open questions

PU(2) monopoles and links of top-level Seiberg-Witten moduli spaces

This is the first of two articles in which we give a proof - for a broad class of four-manifolds - of Witten's conjecture that the Donaldson and Seiberg-Witten series coincide, at least through terms of degree less than or equal to c-2, where c is a linear combination of the Euler characteristic and signature of the four-manifold. This article is a revision of sections 1-3 of an earlier version of the article dg-ga/9712005, now split into two parts, while a revision of sections 4-7 of that earlier version appears in a recently updated dg-ga/9712005. In the present article, we construct virtual normal bundles for the Seiberg-Witten strata of the moduli space of PU(2) monopoles and compute their Chern classes.Comment: Journal fur die Reine und Angewandte Mathematik, to appear; 64 page

HOW RELIABLE IS IN SITU SATURATION MONITORING (ISSM) USING X-RAY?

ABSTRACT In core flooding studies, where fluids are injected to mobilize hydrocarbons, X-ray measurements are often used to monitor the hydrocarbon saturations in the core. This is done as a function of the position in the core and as a function of time. The goal is to understand how effective the injected fluids can displace the hydrocarbons, and to measure how much hydrocarbons are left behind in the core. The calculation of in place saturations from X-ray, however, is not straightforward, and it is often unclear what the uncertainties in the calculated saturations are. In this paper, we compare calculated saturations from X-ray with saturations from direct measurement of produced hydrocarbon volumes from the core. The direct measurement is obtained using a novel apparatus which measures the production of oil using a balance under a back pressure. We show that differences between the two methods can be quite substantial and we discuss what may be the reasons causing these differences. The paper ends with a discussion on how we can improve the use of in situ saturation monitoring for unsteady state experiments

Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.

Aims: Inflammation and organ failure have been reported to have an impact on cytochrome P450 (CYP) 3A-mediated clearance of midazolam in critically ill children. Our aim was to evaluate a previously developed population pharmacokinetic model both in critically ill children and other populations, in order to allow the model to be used to guide dosing in clinical practice. Methods: The model was evaluated externally in 136 individuals, including (pre)term neonates, infants, children and adults (body weight 0.77–90 kg, C-reactive protein level 0.1–341 mg l–1 and 0–4 failing organs) using graphical and numerical diagnostics. Results: The pharmacokinetic model predicted midazolam clearance and plasma concentrations without bias in postoperative or critically ill paediatric patients and term neonates [median prediction error (MPE) 180%). Conclusion: The recently published pharmacokinetic model for midazolam, quantifying the influence of maturation, inflammation and organ failure in children, yields unbiased clearance predictions and can therefore be used for dosing instructions in term neonates, children and adults with varying levels of critical illness, including healthy adults, but not for extrapolation to preterm neonates

Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure

Aims: Inflammation and organ failure have been reported to have an impact on cytochrome P450 (CYP) 3A-mediated clearance of midazolam in critically ill children. Our aim was to evaluate a previously developed population pharmacokinetic model both in critically ill children and other populations, in order to allow the model to be used to guide dosing in clinical practice. Methods: The model was evaluated externally in 136 individuals, including (pre)term neonates, infants, children and adults (body weight 0.77-90 kg, C-reactive protein level 0.1-341 mg l-1 and 0-4 failing organs) using graphical and numerical diagnostics. Results: The pharmacokinetic model predicted midazolam clearance and plasma concentrations without bias in postoperative or critically ill paediatric patients and term neonates [median prediction error (MPE) 180%). Conclusion: The recently published pharmacokinetic model for midazolam, quantifying the influence of maturation, inflammation and organ failure in children, yields unbiased clearance predictions and can therefore be used for dosing instructions in term neonates, children and adults with varying levels of critical illness, including healthy adults, but not for extrapolation to preterm neonates

The origin of non-thermal fluctuations in multiphase flow in porous media

Core flooding experiments to determine multiphase flow in properties of rock such as relative permeability can show significant fluctuations in terms of pressure, saturation, and electrical conductivity. That is typically not considered in the Darcy scale interpretation but treated as noise. However, in recent years, flow regimes that exhibit spatio-temporal variations in pore scale occupancy related to fluid phase pressure changes have been identified. They are associated with topological changes in the fluid configurations caused by pore-scale instabilities such as snap-off. The common understanding of Darcy-scale flow regimes is that pore-scale phenomena and their signature should have averaged out at the scale of representative elementary volumes (REV) and above. In this work, it is demonstrated that pressure fluctuations observed in centimeter-scale experiments commonly considered Darcy-scale at fractional flow conditions, where wetting and non-wetting phases are co-injected into porous rock at small (<10−6) capillary numbers are ultimately caused by pore-scale processes, but there is also a Darcy-scale fractional flow theory aspect. We compare fluctuations in fractional flow experiments conducted on samples of few centimeters size with respective experiments and in-situ micro-CT imaging at pore-scale resolution using synchrotron-based X-ray computed micro-tomography. On that basis we can establish a systematic causality from pore to Darcy scale. At the pore scale, dynamic imaging allows to directly observe the associated breakup and coalescence processes of non-wetting phase clusters, which follow “trajectories” in a “phase diagram” defined by fractional flow and capillary number and can be used to categorize flow regimes. Connected pathway flow would be represented by a fixed point, whereas processes such as ganglion dynamics follow trajectories but are still overall capillary-dominated. That suggests that the origin of the pressure fluctuations observed in centimeter-sized fractional flow experiments are capillary effects. The energy scale of the pressure fluctuations corresponds to 105-106 times the thermal energy scale. This means the fluctuations are non-thermal. At the centimeter scale, there are non-monotonic and even oscillatory solutions permissible by the fractional flow theory, which allow the fluctuations to be visible and—depending on exact conditions—significant at centimeter scale, within the viscous limit of classical (Darcy scale) fractional flow theory. That also means that the phenomenon involves both capillary aspects from the pore or cluster scale and viscous aspects of fractional flow and occurs right at the transition, where the physical description concept changes from pore to Darcy scale

Are mice good models for human neuromuscular disease? Comparing muscle excursions in walking between mice and humans

The mouse is one of the most widely used animal models to study neuromuscular diseases and test new therapeutic strategies. However, findings from successful pre-clinical studies using mouse models frequently fail to translate to humans due to various factors. Differences in muscle function between the two species could be crucial but often have been overlooked. The purpose of this study was to evaluate and compare muscle excursions in walking between mice and humans

Useful pharmacodynamic endpoints in children: selection, measurement, and next steps.

Pharmacodynamic (PD) endpoints are essential for establishing the benefit-to-risk ratio for therapeutic interventions in children and neonates. This article discusses the selection of an appropriate measure of response, the PD endpoint, which is a critical methodological step in designing pediatric efficacy and safety studies. We provide an overview of existing guidance on the choice of PD endpoints in pediatric clinical research. We identified several considerations relevant to the selection and measurement of PD endpoints in pediatric clinical trials, including the use of biomarkers, modeling, compliance, scoring systems, and validated measurement tools. To be useful, PD endpoints in children need to be clinically relevant, responsive to both treatment and/or disease progression, reproducible, and reliable. In most pediatric disease areas, this requires significant validation efforts. We propose a minimal set of criteria for useful PD endpoint selection and measurement. We conclude that, given the current heterogeneity of pediatric PD endpoint definitions and measurements, both across and within defined disease areas, there is an acute need for internationally agreed, validated, and condition-specific pediatric PD endpoints that consider the needs of all stakeholders, including healthcare providers, policy makers, patients, and families.Pediatric Research advance online publication, 11 April 2018; doi:10.1038/pr.2018.38

Controlled Radical Polymerization of Vinyl Acetate Mediated by a Bis(imino)pyridine Vanadium Complex

Source type: Prin